Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
暂无分享,去创建一个
E. de Azambuja | K. Punie | C. Oing | M. Lambertini | T. Amaral | P. Vuylsteke | E. Kocakavuk | A. Matikas | A. Berghoff | M. Kfoury | P. Mandó | C. Cardone | A. Starzer | M. Moutafi | D. Güven | R. Sánchez-Bayona | S. C. Altuna | E. Mariamidze | R. Pihlak | A. Tečić Vuger | E. Connolly | A. Cervantes | P. Sobczuk | R. Canario | C. Westphalen | S. Banerjee | K.H.J. Lim | H. Zhu | M. Cruz-Ordinario | J. Mateo
[1] S. Fröhling,et al. The coming decade in precision oncology: six riddles , 2022, Nature reviews. Cancer.
[2] I. Tannock,et al. Priorities for cancer research in low- and middle-income countries: a global perspective , 2022, Nature Medicine.
[3] R. West,et al. Ten years of NIHR research training: who got an award? A retrospective cohort study , 2022, BMJ Open.
[4] R. Jagsi,et al. Mentoring Underrepresented Minority Physician-Scientists to Success , 2021, Academic medicine : journal of the Association of American Medical Colleges.
[5] H. Wildiers,et al. Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey , 2021, ESMO open.
[6] Amitej Venapally,et al. Challenges and advice for MD/PhD applicants who are underrepresented in medicine , 2020, Molecular biology of the cell.
[7] D. Daye,et al. Factors associated with underrepresented minority physician scientist trainee career choices , 2020, BMC Medical Education.
[8] Kizzmekia Corbett,et al. The duty to mentor, be visible and represent , 2020, Nature Medicine.
[9] C. Swanton. Take lessons from cancer evolution to the clinic , 2020, Nature.
[10] S. Loi,et al. Securing the future of the clinician-scientist , 2020, Nature Cancer.
[11] S. Loi. Around the world and back again , 2019, Nature Medicine.
[12] Nicole N. Woods,et al. Critical Gaps in Understanding the Clinician-Scientist Workforce: Results of an International Expert Meeting. , 2019, Academic medicine : journal of the Association of American Medical Colleges.
[13] A. Ilbawi,et al. Delays and Barriers to Cancer Care in Low‐ and Middle‐Income Countries: A Systematic Review , 2019, The oncologist.
[14] B. Kobilka,et al. Saving the Endangered Physician-Scientist - A Plan for Accelerating Medical Breakthroughs. , 2019, The New England journal of medicine.
[15] Toshio Shimizu,et al. Challenges and insights of early phase oncology drug development in the Asia-Pacific region. , 2019, Chinese clinical oncology.
[16] K. Kaushik. Defining the path of a physician–scientist , 2019, Nature Medicine.
[17] S. Turajlic. Standing on the shoulders of giants , 2019, Nature Medicine.
[18] W. Koh,et al. Factors influencing career progress for early stage clinician-scientists in emerging Asian academic medical centres: a qualitative study in Singapore , 2018, BMJ Open.
[19] A. Mathew. Global Survey of Clinical Oncology Workforce , 2018, Journal of global oncology.
[20] Y. Alamri. The combined medical/PhD degree: a global survey of physician-scientist training programmes. , 2016, Clinical medicine.
[21] L. Rosenberg. Physician-Scientists--Endangered and Essential , 1999, Science.
[22] J. Wyngaarden. The clinical investigator as an endangered species. , 1979, The New England journal of medicine.
[23] J. Soria. Moving from academia to industry in the field of oncology. , 2019, Clinical advances in hematology & oncology : H&O.